The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
Open accessAbstract
BACKGROUND: Persistent patent ductus arteriosus (PDA) is associated with mortality and morbidity in preterm infants. Prostaglandin synthetase inhibitors such as indomethacin promote PDA closure but also have potential side effects. The effect of the prophylactic use of indomethacin, where infants who may not have gone on to develop a symptomatic PDA would be exposed to indomethacin, warrants particular scrutiny. OBJECTIVES: To determine the effect of prophylactic indomethacin on mortality and morbidity in preterm infants. SEARCH STRATEGY: The standard search strategy of the Cochrane Neonatal Review Group was used. This included searches of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 5, 2010), MEDLINE, EMBASE and CINAHL (until April 2010), conference proceedings, and previous reviews. SELECTION CRITERIA: Randomised or quasi-randomised controlled trials that compared prophylactic indomethacin versus placebo or no drug in preterm infants. DATA COLLECTION AND ANALYSIS: The standard methods of the Cochrane Neonatal Review Group were used, with separate evaluation of trial quality and data extraction by two review authors. MAIN RESULTS: Nineteen eligible trials in which 2872 infants participated were identified. Most participants were very low birth weight, but the largest single trial restricted participation to extremely low birth weight infants (N = 1202). The trials were generally of good quality.The incidence of symptomatic PDA [typical relative risk (RR) 0.44, 95% confidence interval (CI) 0.38 to 0.50] and PDA surgical ligation (typical RR 0.51, 95% CI 0.37,0.71) was significantly lower in treated infants. Prophylactic indomethacin also significantly reduced the incidence of severe intraventricular haemorrhage (typical RR 0.66, 95% CI 0.53 to 0.82). Meta-analyses found no evidence of an effect on mortality (typical RR 0.96, 95% CI 0.81 to 1.12) or on a composite of death or severe neurodevelopmental disability assessed at 18 to 36 months old (typical RR 1.02, 95% CI 0.90, 1.15). AUTHORS' CONCLUSIONS: Prophylactic indomethacin has short-term benefits for preterm infants including a reduction in the incidence of symptomatic PDA, PDA surgical ligation, and severe intraventricular haemorrhage. However, there is no evidence of effect on mortality or neurodevelopment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Papile, L.-A., Burstein, J., Burstein, R., & Koffler, H. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80282-0 · Cited by 6,430
An international classification of retinopathy of prematurity
(1985) · International Ophthalmology · doi:10.1007/bf00136454 · Cited by 1,005
Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight Infants
Schmidt, B., Davis, P., Moddemann, D., Ohlsson, A., Roberts, R. S., Saigal, S., Solimano, A., Vincer, M., & Wright, L. L. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442602 · Cited by 725
Self-citationClosure of the Ductus Arteriosus in Premature Infants by Inhibition of Prostaglandin Synthesis
Heymann, M. A., Rudolph, A. M., & Silverman, N. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609022951004 · Cited by 511
Low‐dose indomethacin and prevention of intraventricular hemorrhage: A multicenter randomized trial
Ment, L. R., Ehrenkranz, R. A., Duncan, C. C., Scott, D. T., Taylor, K. J. W., Katz, K. H., Schneider, K. C., Makuch, R. W., Oh, W., Vohr, B., et al. (1994) · Pediatrics · doi:10.1542/peds.93.4.543 · Cited by 385
An International Classification of Retinopathy of Prematurity
(1984) · Pediatrics · doi:10.1542/peds.74.1.127 · Cited by 309
Effects of indomethacin on cerebral haemodynamics in very preterm infants
Edwards, A. D., Wyatt, J. S., Richardson, C., Potter, A., Reynolds, E. O. R., Cope, M., & Delpy, D. T. (1990) · The Lancet · doi:10.1016/0140-6736(90)93030-s · Cited by 296
Early determinants of right and left ventricular output in ventilated preterm infants.
Evans, N., & Kluckow, M. (1996) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.74.2.f88 · Cited by 268
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants
Ohlsson, A., Walia, R., & Shah, S. S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003481.pub5 · Cited by 263
Kitterman, J. A., Edmunds, L. H., Gregory, G. A., Heymann, M. A., Tooley, W. H., & Rudolph, A. M. (1972) · New England Journal of Medicine · doi:10.1056/nejm197209072871001 · Cited by 228
Cited by
Brok, J., Thorlund, K., Wetterslev, J., & Gluud, C. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn188 · Cited by 917
Patent Ductus Arteriosus of the Preterm Infant
Hamrick, S. E. G., & Hansmann, G. (2010) · Pediatrics · doi:10.1542/peds.2009-3506 · Cited by 543
Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants
Kaufman, D., & Fairchild, K. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.3.638-680.2004 · Cited by 435
Epidemiology of bronchopulmonary dysplasia
Jensen, E. A., & Schmidt, B. (2014) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.23235 · Cited by 419
Towards rational management of the patent ductus arteriosus: the need for disease staging: Table 1
McNamara, P. J., & Sehgal, A. (2007) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/adc.2007.118117 · Cited by 384
Benitz, W. E. (2010) · Journal of Perinatology · doi:10.1038/jp.2010.3 · Cited by 345
Ohlsson, A., Walia, R., & Shah, S. S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003481.pub6 · Cited by 334
Pathogenesis and Prevention of Intraventricular Hemorrhage
Ballabh, P. (2014) · Clinics in Perinatology · doi:10.1016/j.clp.2013.09.007 · Cited by 319
Robinson, S. (2012) · Journal of Neurosurgery: Pediatrics · doi:10.3171/2011.12.peds11136 · Cited by 297
Clyman, R. I., Couto, J., & Murphy, G. M. (2012) · Seminars in Perinatology · doi:10.1053/j.semperi.2011.09.022 · Cited by 292
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants
Ohlsson, A., Walia, R., & Shah, S. S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003481.pub5 · Cited by 263
Alderliesten, T., Lemmers, P. M. A., Smarius, J. J. M., van de Vosse, R. E., Baerts, W., & van Bel, F. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.09.038 · Cited by 254
Metadata
- Authors
- Fowlie, P. W., Davis, P. G., & McGuire, W.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-07-07
- Issue
- 7
- Pages
- CD000174-CD000174
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1578545245
- Cited by
- 480
- References
- 37
- FWCI
- 25.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.